Emergent BioSolutions (EBS) Change in Acquisitions & Divestments (2010 - 2012)
Emergent BioSolutions (EBS) posted Change in Acquisitions & Divestments of $2.0 million for Q1 2012, up 293.2% on a QoQ basis from $500000.0 in Q4 2011.
Powered by 
Analysis
Emergent BioSolutions (EBS) Change in Acquisitions & Divestments (2010 - 2012) Analysis & Trends
Emergent BioSolutions has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $2.0 million in Q1 2012.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million in Q1 2012; TTM through Dec 2012 was $2.0 million, a 53.74% decrease from a year earlier, with the FY2012 full-year figure at $2.0 million, down 53.74% from the prior year.
- Change in Acquisitions & Divestments was $2.0 million for Q1 2012 at Emergent BioSolutions, up from $500000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $10.0 million in Q4 2010, with the low at $500000.0 in Q4 2011.
- Average Change in Acquisitions & Divestments over 3 years is $3.2 million, with a median of $2.0 million recorded in 2012.
- The largest YoY upside for Change in Acquisitions & Divestments was 95.0% in 2011 against a maximum downside of 95.0% in 2011.
- Over 3 years, Change in Acquisitions & Divestments stood at $10.0 million in 2010, then tumbled by 95.0% to $500000.0 in 2011, then jumped by 293.2% to $2.0 million in 2012.
- The last three Change in Acquisitions & Divestments figures came in at $2.0 million (Q1 2012), $500000.0 (Q4 2011), and $1.5 million (Q3 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2012 | 1.97 Mn |
| Dec 31, 2011 | 500,000.00 |
| Sep 30, 2011 | 1.50 Mn |
| Jun 30, 2011 | 2.25 Mn |
| Dec 31, 2010 | 10.00 Mn |
API Access
Emergent BioSolutions Change in Acquisitions & Divestments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-acquisitions-and-divestments", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();